Company Filing History:
Years Active: 2001-2003
Title: S Shane Taremi: Innovator in Hepatitis C Research
Introduction
S Shane Taremi is a notable inventor based in Upper Montclair, NJ (US). He has made significant contributions to the field of hepatitis C research, holding a total of 2 patents. His work focuses on the development of recombinant complexes that play a crucial role in understanding and potentially treating hepatitis C virus infections.
Latest Patents
Taremi's latest patents include innovative solutions such as the "Single-chain recombinant complexes of hepatitis C virus NS3 protease and NS4A cofactor peptide." This patent describes covalent HCV NS4A-NS3 complexes that comprise the central hydrophobic domain of native HCV NS4A peptide, a linker, and the HCV NS3 serine protease domain. The hydrophobic domain of the native HCV NS4A peptide is tethered by the linker to the amino terminus of the HCV NS3 protease domain. This groundbreaking work aims to enhance the understanding of the virus's mechanisms and improve therapeutic strategies.
Career Highlights
S Shane Taremi is associated with Schering Corporation, where he has been instrumental in advancing research related to hepatitis C. His expertise and innovative approach have positioned him as a key figure in the field.
Collaborations
Taremi has collaborated with notable colleagues such as Bruce A Malcolm and Patricia C Weber, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
S Shane Taremi's contributions to hepatitis C research through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in understanding and treating this challenging virus.